2019

Testbiotech comment on EFSA’s assessment of genetically engineered soybean MON87751 x MON87701 x MON87708 x MON89788 by Bayer/Monsanto

TESTBIOTECH Background 08 - 12 -2019

The GMO panel assessed the four-stacked soybean event MON87751 x MON87701 x MON87708 x MON89788 derived from crossing genetically engineered soybean events. The parental soybeans have undergone previous assessment (EFSA, 2019a). The soybean contains genes conferring resistance to two herbicides:• MON87751 expressing the insecticidal proteins Cry1A.105 and Cry2Ab2, with Cry1A.105 being synthetic without natural template;• weiterlesen

Testbiotech comment on ‘Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-UK-2006-34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272’ by company Syngenta

TESTBIOTECH Background 4 - 12 - 2019

The EFSA GMO Panel assessed maize 3272, which produces an artificial enzyme belonging the group of alpha-amylase. This enzyme (thermos-tolerant alpha-amylase AMY797E) is supposed to have a positive effect on the processing of the maize kernels at high temperatures, especially when intended for use in producing agro-fuels. Maize 3272 was developed for use in the weiterlesen

Testbiotech comment on EFSA’s assessment of genetically engineered maize MIR604 for renewal authorisation from Syngenta

TESTBIOTECH Background 8 - 12 - 2019

The EFSA GMO panel assessed the renewal application for maize MIR604. The maize expresses genes producing a synthetic, artificial version of Cry3A (mCry3A), which is especially toxic for Coleoptera species (such as the Western corn rootworm larvae, Diabrotica virgifera virgifera). Further, the maize produces the PMI protein (phosphomannose isomerase) derived from Escherichia coli. Expression of weiterlesen

Testbiotech comment on EFSA’s assessment of genetically engineered maize MON87427 x MON89034 x MIR162 x MON87411 and subcombinations from Bayer/Monsanto

TESTBIOTECH Background 8 - 12 - 2019

The EFSA GMO panel assessed the four-stacked maize MON87427 x MON89034 x MIR162 x MON87411, which is derived from crossing genetically engineered maize events (EFSA, 2019f). The parental plants were assessed by EFSA in previous opinions. The maize contains genes conferring doubled resistance to glyphosate and produces three insecticides:• MON87427 expressing CP4 EPSPS protein for weiterlesen

Differences between conventional breeding and genetic engineering: An assessment of the statement made by the Group of Chief Scientific Advisors’ (SAM)

TESTBIOTECH Background 04 - 12 - 2019

IntroductionTestbiotech became aware of the ‘Statement by the Group of Chief Scientific Advisors’ (SAM), titled: “A Scientific Perspective on the Regulatory Status of Products Derived from Gene Editing and the Implications for the GMO Directive” (SAM 2018). After detailed analysis, we concluded that this statement needs to be revised. Many of the arguments used in weiterlesen

Testbiotech comment on EFSA’s assessment of genetically engineered maize MON 87427 x MON87460 x MON 89034 x MIR162 x NK603 and subcombinations (application EFSA-GMO-NL- 2016-131) from Bayer / Monsanto (October 2019)

The EFSA GMO panel assessed the five-stacked maize MON 87427 x MON87460 x MON 89034 x MIR162 x NK603, which is derived from crossing genetically engineered maize events (EFSA, 2019a). The parental plants were assessed by EFSA in previous opinions. The maize contains genes conferring triple resistance to glyphosate and produces three insecticides, further it weiterlesen